Aarti Pharmalabs Board Meeting on Aug 7 to Approve Unaudited Results

Aarti Pharmalabs Ltd has announced that its Board of Directors will convene on August 7, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2026. These results will be presented on both a standalone and consolidated basis, accompanied by the auditors' limited review reports. Concurrently, the company has informed that the trading window for its securities, which opened on July 1, 2026, will remain closed until August 9, 2026, to facilitate the announcement of these financial results and prevent insider trading.